"Infusional therapy including chemotherapy, hydration, and other medication"

During the past decade, Geisinger Medical Oncology-Selinsgrove conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 26 clinical trials were completed, i.e. on average, 36.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 26 clinical trials were completed. i.e. 162.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geisinger Medical Oncology-Selinsgrove" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Medical Oncology-Selinsgrove" #1 collaborator was "National Cancer Institute (NCI)" with 46 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Geisinger Medical Oncology-Selinsgrove" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "HER2/Neu Negative" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Geisinger Medical Oncology-Selinsgrove" in a lesser frequency.

Most popular intervention types in "Geisinger Medical Oncology-Selinsgrove" are "Drug" (63 trials), "Other" (55 trials), "Biological" (29 trials), "Procedure" (22 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (22 trials), "Computed Tomography" (15 trials), "Questionnaire Administration" (14 trials) and "Biospecimen Collection" (12 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Medical Oncology-Selinsgrove" are 68 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Geisinger Medical Oncology-Selinsgrove". undefined are not yet recruiting, 20 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Geisinger Medical Oncology-Selinsgrove, 2 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Medical Oncology-Selinsgrove, 2 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".